CD8A and cancer: Statins may enhance the response to immune checkpoint blockade and therapeutic efficacy in cancer models.17, 18, 19 We therefore explored if HIV-specific CD8+ T cells from samples at W12 of rosuvastatin treatment were more able to respond to immune checkpoint blockade.